Search

Your search keyword '"Dzintars Gotham"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Dzintars Gotham" Remove constraint Author: "Dzintars Gotham" Topic business Remove constraint Topic: business
26 results on '"Dzintars Gotham"'

Search Results

1. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2. Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials

3. Variation in the prices of oncology medicines across Europe and the implications for the future

4. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

5. Public investments in the clinical development of bedaquiline

6. Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States

7. Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

8. Candidates for inclusion in a universal antiretroviral regimen

9. Quantifying changes in global health inequality: the Gini and Slope Inequality Indices applied to the Global Burden of Disease data, 1990–2017

10. Pricing of oral generic cancer medicines in 25 European countries; findings and implications

11. Patent pooling to increase access to essential medicines

12. How a US-UK trade agreement could affect NHS drug prices

13. Estimated costs of production and potential prices for the WHO Essential Medicines List

14. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

15. Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

16. Potential price reductions for cancer medicines on the WHO Essential Medicines List

17. Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List

18. Estimated generic prices for novel treatments for drug resistant tuberculosis

19. Production costs and potential prices for biosimilars of human insulin and insulin analogues

20. Drug prices threaten the NHS

21. How the MDGs gave up on measuring access to medicines

22. Generic treatments for human immunodeficiency virus, hepatitis B virus, hepatitis C virus, TB could be mass-produced for <$90 per patient

23. Significant Reductions in Costs of Generic Production of Sofosbuvir and Daclatasvir for Hepatitis C Treatment in Low- and Middle-Income Countries

24. Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

26. Global health equity in United Kingdom university research: a landscape of current policies and practices

Catalog

Books, media, physical & digital resources